Stamford, Conn.-based AmbioHealth raised $525,000 in equity to close out its third angel round. The company will use the money to continue developing its remote health monitoring system and its compatible activity monitoring system, CEO and Co-Founder Kevin Jones said. The money will also go toward marketing and operational costs.
Jones said the company aimed to raise $500,000, but between existing investors and one new investor ended up 5 percent over.
The Ambio Remote Health Monitoring System received 510(k) clearance less than a month ago, and is commercially available, as are the monitors.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
According to the regulatory filing, officers and directors include Jones, formerly a partner at Accenture; Co-Founder Alden Stevens, formerly CIO at Reynders, Gray and Co.; and Director Robert D’Alessandro.